AR and prostate cancer: Yoshida Yoshida S S Kajiwara Kajiwara D D Seki Seki M M TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer Mol Oncol Mol Oncol 2024 2024 18 18 1980 1980 2000 2000 10.1002/1878-0261.13641 10.1002/1878-0261.13641 supplied-pmid 38600681?